Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2011 (2011), Article ID 412524, 4 pages
http://dx.doi.org/10.1155/2011/412524
Case Report

A Case of Montelukast-Induced Churg-Strauss Syndrome Associated with Liver Dysfunction

1Center for Digestive and Liver Disease, Ofuna Chuo Hospital, 6-2-24 Ofuna, Kamakura-city, Kanagawa 247-0056, Japan
2Kamakura Internal Medicine Clinic, 736 Yamanouchi, Kamakura-city, Kanagawa 247-0062, Japan

Received 9 May 2011; Accepted 2 June 2011

Academic Editors: J. M. F. Chebli and D. Lorenzin

Copyright © 2011 Keiji Matsui and Kosuke Nishijima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Churg, “Recent advances in the diagnosis of Churg-Strauss syndrome,” Modern Pathology, vol. 14, no. 12, pp. 1284–1293, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. N. Hattori, M. Ichimura, M. Nagamatsu et al., “Clinicopathological features of Churg-Strauss syndrome-associated neuropathy,” Brain, vol. 122, no. 3, pp. 427–439, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Conen, J. Leuppie, L. Bubendorf, A. Ronsdorf, M. Tamm, and T. Hauser, “Montelukast and Churg-Strauss syndrome,” Swiss Medical Weekly, vol. 134, no. 25-26, pp. 377–380, 2004. View at Google Scholar · View at Scopus
  4. A. B. Michael and D. Murphy, “Montelukast-associated Churg-Strauss syndrome,” Age and Ageing, vol. 32, no. 5, pp. 551–552, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. F. McAuley, V. McGovern, P. T. Dick, J. T. Lawson, and J. MacMahon, “Churg-Strauss syndrome associated with leukotriene receptor antagonists,” Ulster Medical Journal, vol. 70, no. 2, pp. 152–154, 2001. View at Google Scholar · View at Scopus
  6. P. Guilpain, J. F. Viallard, P. Lagarde et al., “Churg-Strauss syndrome in two patients receiving montelukast,” Rheumatology, vol. 41, no. 5, pp. 535–539, 2002. View at Google Scholar · View at Scopus
  7. R. S. Katz, M. Papernik, R. W. Honsinger et al., “Zafirlukast and Churg-Strauss syndrome,” Journal of the American Medical Association, vol. 279, no. 24, pp. 1949–1950, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Singer and R. A. F. Clark, “Cutaneous wound healing,” The New England Journal of Medicine, vol. 341, no. 10, pp. 738–746, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Green, R. A. Stockton, C. Johnson, and B. S. Jacobson, “5-lipoxygenase and cyclooxygenase regulate wound closure in NIH/3T3 fibroblast monolayers,” American Journal of Physiology, vol. 287, no. 2, pp. C373–C383, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. H. Phan, B. M. McGarry, K. M. Loeffler, and S. L. Kunkel, “Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites,” Journal of Leukocyte Biology, vol. 42, no. 2, pp. 106–113, 1987. View at Google Scholar · View at Scopus
  11. G. Szebenyi, E. W. Dent, J. L. Callaway, C. Seys, H. Lueth, and K. Kalil, “Fibroblast growth factor-2 promotes axon branching of cortical neurons by influencing morphology and behavior of the primary growth cone,” Journal of Neuroscience, vol. 21, no. 11, pp. 3932–3941, 2001. View at Google Scholar · View at Scopus
  12. N. R. Smalheiser, S. Dissanayake, and A. Kapil, “Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites,” Brain Research, vol. 721, no. 1-2, pp. 39–48, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Classen, W. O. Gunson, V. M. Traina, M. H. Vonau, and G. J. Krinke, “Functional and morphological characterization of neuropathy induced with 5-lipoxygenase inhibitor CGS 21595,” Experimental and Toxicologic Pathology, vol. 46, no. 2, pp. 119–125, 1994. View at Google Scholar
  14. L. Drynan, P. A. Quant, and V. A. Zammit, “The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat,” Biochemical Journal, vol. 318, no. 3, pp. 767–770, 1996. View at Google Scholar · View at Scopus
  15. T. Ito, N. Sugiyama, M. Kobayashi et al., “Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug,” Tohoku Journal of Experimental Medicine, vol. 175, no. 1, pp. 43–53, 1995. View at Google Scholar · View at Scopus